Caprock Group LLC Boosts Stock Holdings in Welltower Inc. (NYSE:WELL)

Caprock Group LLC lifted its holdings in shares of Welltower Inc. (NYSE:WELL) by 9.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,372 shares of the real estate investment trust’s stock after buying an additional 843 shares during the quarter. Caprock Group LLC’s holdings in Welltower were worth $1,181,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Retirement Systems of Alabama lifted its position in shares of Welltower by 3.7% during the third quarter. Retirement Systems of Alabama now owns 470,419 shares of the real estate investment trust’s stock worth $60,228,000 after acquiring an additional 16,946 shares in the last quarter. Barclays PLC lifted its holdings in Welltower by 29.2% during the 3rd quarter. Barclays PLC now owns 1,684,446 shares of the real estate investment trust’s stock worth $215,659,000 after purchasing an additional 380,888 shares in the last quarter. Diversified Trust Co boosted its stake in Welltower by 93.8% in the 3rd quarter. Diversified Trust Co now owns 18,474 shares of the real estate investment trust’s stock worth $2,365,000 after purchasing an additional 8,940 shares during the period. Park Avenue Securities LLC grew its holdings in Welltower by 20.1% during the 4th quarter. Park Avenue Securities LLC now owns 13,456 shares of the real estate investment trust’s stock valued at $1,696,000 after buying an additional 2,250 shares in the last quarter. Finally, Nordea Investment Management AB increased its position in shares of Welltower by 28.1% during the fourth quarter. Nordea Investment Management AB now owns 1,477,388 shares of the real estate investment trust’s stock valued at $185,649,000 after buying an additional 324,520 shares during the period. 94.80% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Raymond James raised their price objective on shares of Welltower from $145.00 to $155.00 and gave the company a “strong-buy” rating in a research report on Monday, December 16th. Mizuho upped their price target on shares of Welltower from $136.00 to $141.00 and gave the stock an “outperform” rating in a report on Thursday, December 5th. Jefferies Financial Group upgraded Welltower from a “hold” rating to a “buy” rating and increased their price objective for the stock from $132.00 to $147.00 in a research report on Thursday, January 2nd. StockNews.com upgraded Welltower from a “sell” rating to a “hold” rating in a research report on Wednesday, October 30th. Finally, Bank of America raised their price target on Welltower from $190.00 to $221.00 and gave the company a “buy” rating in a report on Friday, January 24th. Five investment analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $134.96.

Welltower Trading Down 0.5 %

WELL stock opened at $136.49 on Monday. The company has a market capitalization of $84.99 billion, a PE ratio of 89.80, a price-to-earnings-growth ratio of 2.68 and a beta of 1.22. The company has a debt-to-equity ratio of 0.51, a quick ratio of 4.10 and a current ratio of 4.10. Welltower Inc. has a one year low of $85.40 and a one year high of $140.75. The company’s 50 day moving average price is $130.04 and its two-hundred day moving average price is $126.49.

About Welltower

Welltower Inc (NYSE:WELL), a real estate investment trust (“REIT”) and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience.